Peters S, Mundree SG, Thomson JA, Farrant JM, Keller F
Epp O, Ladenstein R, Wendel A (1983) The refined structure of the selenoenzyme glutathione peroxidase at 0.2-nm resolution
GLP-1 therapy is particularly considered in patients with a BMI 35 kg/m or those who would benefit from weight loss
Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity - Diabetes, Obesity & Metabolism Dosing schedule - Ozempic Once-Weekly Semaglutide in Adults with Overweight or Obesity - New England Journal of Medicine Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity - JAMA Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial - Lancet